223 related articles for article (PubMed ID: 27767993)
1. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
Cummings J; Scheltens P; McKeith I; Blesa R; Harrison JE; Bertolucci PH; Rockwood K; Wilkinson D; Wijker W; Bennett DA; Shah RC
J Alzheimers Dis; 2017; 55(3):1131-1139. PubMed ID: 27767993
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.
Scheltens P; Twisk JW; Blesa R; Scarpini E; von Arnim CA; Bongers A; Harrison J; Swinkels SH; Stam CJ; de Waal H; Wurtman RJ; Wieggers RL; Vellas B; Kamphuis PJ
J Alzheimers Dis; 2012; 31(1):225-36. PubMed ID: 22766770
[TBL] [Abstract][Full Text] [Related]
3. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study.
de Waal H; Stam CJ; Lansbergen MM; Wieggers RL; Kamphuis PJ; Scheltens P; Maestú F; van Straaten EC
PLoS One; 2014; 9(1):e86558. PubMed ID: 24475144
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
Olde Rikkert MG; Verhey FR; Blesa R; von Arnim CA; Bongers A; Harrison J; Sijben J; Scarpini E; Vandewoude MF; Vellas B; Witkamp R; Kamphuis PJ; Scheltens P
J Alzheimers Dis; 2015; 44(2):471-80. PubMed ID: 25322923
[TBL] [Abstract][Full Text] [Related]
5. Souvenaid for Alzheimer's disease.
Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
[TBL] [Abstract][Full Text] [Related]
6. The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?
Rasmussen J
Clin Interv Aging; 2019; 14():1481-1492. PubMed ID: 31616139
[TBL] [Abstract][Full Text] [Related]
7. Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.
Rijpma A; Meulenbroek O; van Hees AM; Sijben JW; Vellas B; Shah RC; Bennett DA; Scheltens P; Olde Rikkert MG
Alzheimers Res Ther; 2015; 7(1):51. PubMed ID: 26213579
[TBL] [Abstract][Full Text] [Related]
8. Souvenaid®: a new approach to management of early Alzheimer's disease.
Ritchie CW; Bajwa J; Coleman G; Hope K; Jones RW; Lawton M; Marven M; Passmore P
J Nutr Health Aging; 2014 Mar; 18(3):291-9. PubMed ID: 24626757
[TBL] [Abstract][Full Text] [Related]
9. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.
Shah RC; Kamphuis PJ; Leurgans S; Swinkels SH; Sadowsky CH; Bongers A; Rappaport SA; Quinn JF; Wieggers RL; Scheltens P; Bennett DA
Alzheimers Res Ther; 2013; 5(6):59. PubMed ID: 24280255
[TBL] [Abstract][Full Text] [Related]
10. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
[TBL] [Abstract][Full Text] [Related]
12. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.
Engelborghs S; Gilles C; Ivanoiu A; Vandewoude M
Acta Clin Belg; 2014; 69(1):17-24. PubMed ID: 24635394
[TBL] [Abstract][Full Text] [Related]
13. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion.
Cummings J; Passmore P; McGuinness B; Mok V; Chen C; Engelborghs S; Woodward M; Manzano S; Garcia-Ribas G; Cappa S; Bertolucci P; Chu LW
Alzheimers Res Ther; 2019 Aug; 11(1):73. PubMed ID: 31421681
[TBL] [Abstract][Full Text] [Related]
14. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
van Wijk N; Broersen LM; de Wilde MC; Hageman RJ; Groenendijk M; Sijben JW; Kamphuis PJ
J Alzheimers Dis; 2014; 38(3):459-79. PubMed ID: 23985420
[TBL] [Abstract][Full Text] [Related]
15. Nutritional approaches in the risk reduction and management of Alzheimer's disease.
Mi W; van Wijk N; Cansev M; Sijben JW; Kamphuis PJ
Nutrition; 2013 Sep; 29(9):1080-9. PubMed ID: 23756280
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
Onakpoya IJ; Heneghan CJ
Nutr Neurosci; 2017 May; 20(4):219-227. PubMed ID: 26638900
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
18. Food for thought: Souvenaid in mild Alzheimer’s disease.
Cummings JL
J Alzheimers Dis; 2012; 31(1):237-8. PubMed ID: 22766771
[No Abstract] [Full Text] [Related]
19. Alzheimer's Disease Composite Score: A Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease.
Hendrix SB; Soininen H; van Hees AMJ; Ellison N; Visser PJ; Solomon A; Attali A; Blennow K; Kivipelto M; Hartmann T
J Prev Alzheimers Dis; 2019; 6(4):232-236. PubMed ID: 31686094
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
